Zhen Su, CEO at Marengo Therapeutics, recently posted on LinkedIn:

“Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research to fund next-wave oncology innovation. A shoutout to Albert Bourla Chris Boshoff, and Mikael Dolsten for this transformative contribution to the cancer research community!
We are proud of the Merck Group and Pfizer Bavencio alliances and everyone who has contributed to this important partnership especially the early clinical trial investigators at the National Cancer Institute (NCI) led by Dr. James Gulley.”

Source: Zhen Su/LinkedIn